Skip to main content
Log in

Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction

European Section for Infections in Urology has been conducting an annual prevalence survey investigating various aspects of healthcare-associated urinary tract infections (HAUTI) since 2003.

Material and Methods

The data on various clinical categories of HAUTI, the contamination status of HAUTI patients who underwent any urological intervention with regard to microorganisms isolated, resistance status and antibiotics used to treat HAUTI will be presented.

Results

Of a total of 19,756 patients screened, 1,866 patients had HAUTI (9.4 %); 1,313 males (70.4 %) and 553 (29.6 %) females. Mean age was 59.9 ± 18.2. Asymptomatic bacteriuria (ASB) and cystitis were the most frequent clinical diagnoses representing 27.0 and 26 % of all HAUTI, respectively. Echerichia coli was found to be the most frequent uropathogen (544 of 1,371 isolates) (39.7 %). Fluoroquinolones were preferred in 26.6 % of cases followed by cephalosporins (23.3 %), aminoglycosides (14.1 %) and penicillins (13.8 %). High global resistance rates to ciprofloxacin (>50 %), cephalosporins (35–50 %) and penicillins (50 %) were found in the GPIU studies 2003–2010.

Discussion

We showed that around 10 % of hospitalized urological patients are at risk to develop HAUTI often caused by multiresistant uropathogens. Increased antibiotic use often with broad-spectrum antimicrobials will inevitably be followed by increasing bacterial resistance. To interrupt such a vicious cycle, our results suggest (1) there is still room for improvement in surgical prophylaxis in terms of limiting exposure to antibiotics and (2) far too many patients with ASB are being treated which shows that the new proposal of classification should be adopted where ABS is regarded as colonization and not as an infection to be treated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332

    Article  PubMed  Google Scholar 

  2. (http://www.ecdc.europa.eu/en/healthtopics/Healthcare-associated_infections/Pages/index.aspx?MasterPage=1 accessed on 9.1.2013). European centre for disease prevention and control. Annual epidemiological report 2011—Reporting on 2009 surveillance data and 2010 epidemic intelligence data. http://ecdc.europa.eu/en/publications/Publications/1111_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf

  3. Klevens RM, Edwards JR, Richards CL Jr et al (2007) Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 122:160–166

    PubMed Central  PubMed  Google Scholar 

  4. Mathai D, Jones RN, Pfaller MA (2001) Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40(3):129–136

    Article  CAS  PubMed  Google Scholar 

  5. Bouza E, San Juan R, Munoz P et al (2001) A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 7(10):523–531

  6. Kahlmeter G (2000) The ECOSENS project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens—interim report. J Antimicrob Chemother 46(1):15–22 discussion 63–65

    Article  CAS  Google Scholar 

  7. EARRS-The European Antimicrobial Resistance Surveillance System (EARSS, renamed EARS-Net in 2010), ARSS-MT, Advisory Board, and National representatives. EARSS annual report 2008. On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. (2009). Available at: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2008_EARSS_Annual_Report.pdf (last accessed 25 September 2012)

  8. HELICS-European Surveillance of ICU-Acquired Infections (HELICS-ICU): methods and main results C. Suetens* (Brussels), I. Morales (Brussels), A. Savey (Lyon), M. Palomar (Barcelona), M. Hiesmayr(Vienna), A. Lepape (Lyon), P. Gastmeier (Berlin), J.C. Schmit (Luxembourg),R. Valinteliene (Vilnius), J Fabry (Lyon) J Hospital Infect (2007) 65(S2):171–173

  9. NNISS, National Nosocomial Infections Surveillance (NNIS) (2004) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485

    Google Scholar 

  10. Zarb P, Goossens H (2011) European surveillance of antimicrobial consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs 71(6):745–755. doi:10.2165/11591180-000000000-00000

    Article  PubMed  Google Scholar 

  11. SHEA (Society for Healthcare Epidemiology of America) Reports (1997) SHEA Position Paper. Infect Control 18(4): 275–291

  12. Emmerson AM, Enstone JE, Griffin M et al (1996) The second national prevalence survey of infection in hospitals—overview of the results. J Hosp Infect 32:175–190

    Article  CAS  PubMed  Google Scholar 

  13. Gastmeier P, Kampf G, Wischnewski N et al (1998) Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 38:37–49

    Article  CAS  PubMed  Google Scholar 

  14. Lizioli A, Privitera G, Alliata E et al (2003) Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000. J Hosp Infect 54:141–148

    Article  CAS  PubMed  Google Scholar 

  15. Di Pietrantonj C, Ferrara L, Lomolino G (2004) Multicenter study of the prevalence of nosocomial infections in Italian hospitals. Infect Control Hosp Epidemiol 25:85–87

    Article  PubMed  Google Scholar 

  16. Lyytikaäinen O, Kanerva M, Aghte N et al (2008) Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Infect 69:288–294

    Article  Google Scholar 

  17. Smyth ETM, McIlvenny G, Enstone JE et al (2008) Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect 69:230–248

    Article  CAS  PubMed  Google Scholar 

  18. Duo-shuang X, Xiong W, Xiang L et al (2010) Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007–2008. J Hosp Infect 76:150–155

    Article  Google Scholar 

  19. Bjerklund Johansen TE, Cek M, Naber K et al (2007) Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 51(4):1100–1112 discussion 1112

    Article  PubMed  Google Scholar 

  20. Bjerklund Johansen TE, Cek M, Naber K et al (2006) Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics: Data from the PEP and PEAP-studies. Int J Antimicrob Agents 28S:S91–S107

    Article  Google Scholar 

  21. Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P et al Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol. doi:10.1007/s00345-013-1154-8

  22. Bailye TM, Ries NM (2005) Legal issues in patient safety: the example of nosocomial infection. Healthc Q 8:140–145

    Article  Google Scholar 

  23. Durlach R et al (2012) Prevalence survey of healthcare-associated infections in Argentina; comparison with England, Wales, Northern Ireland and South Africa. J Hosp Infect 80(3):217–223

    Article  CAS  PubMed  Google Scholar 

  24. Humphreys H, Smyth ETM (2006) Prevalence surveys of healthcare-associated infections: what do they tell us, if anything? Clin Microbiol Infect 12:2–4

    Article  CAS  PubMed  Google Scholar 

  25. Hansen S, Sohr D, Geffers C et al (2012) Concordance between European and US case definitions of healthcare-associated infections. Antimicrob Resist Infect Control 1:28

    Article  PubMed Central  PubMed  Google Scholar 

  26. EAU Guidelines. Guidelines on Urological Infections. M Grabe (chairman), TE Bjerklund-Johansen, H Botto, M Cek, KG Naber, RS Pickard, P Tenke, F Wagenlehner, B Wullt; members of the European Association of Urology (EAU) Guidelines Office. Guidelines on Chronic Pelvic Pain. In: EAU Guidelines, edition presented at the 25th EAU Annual Congress, Barcelona 2010. ISBN 978-90-79754-70-0

  27. Wagenlehner FME, Cek M, Naber KG et al (2012) Epidemiology, treatment and prevention of healthcare-associated urinary tract infections. World J Urol 30:59–67

    Article  CAS  PubMed  Google Scholar 

  28. Kwon JH, Fausone MK, Du H et al (2012) Impact of laboratory reported urine culture colony counts on the diagnosis and treatment of urinary tract infection for hospitalized patients. Am J Clin Pathol 137:778–784

    Article  PubMed  Google Scholar 

  29. Paterson DL (2004) “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 38(Suppl 4):S341–S345

    Article  CAS  PubMed  Google Scholar 

  30. Bonkat G, Muller G, Braissant O et al Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase producing Echerichia coli urinary isolates. World J Urol. doi:10.1007/s00345-013-1031-5

  31. Çek M, Tandoğdu Z, Naber K et al (2013) On behalf of the global prevalence study of infections in urology investigators. Antibiotic Prophylaxis in Urology Departments, 2005–2010. Eur Urol 63(2):386–394. doi:10.1016/j.eururo.2012.09.038

    Article  PubMed  Google Scholar 

  32. Wilson APR, Gibbons C, Reeves BC et al (2004) Surgical wound infection as a performance indicator; agreement of common definitions of wound infection in 4773 patients. BMJ 329:e1–e5

    Article  Google Scholar 

  33. McNicholas S, Andrews C, Boland K et al (2011) Delayed acute hospital discharge and healthcare-associated infection: the forgotten risk factor. J Hosp Infect 78(2):157–158. doi:10.1016/j.jhin.2011.03.001

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are thankful for the urologists who contributed kindly to the studies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mete Cek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cek, M., Tandoğdu, Z., Wagenlehner, F. et al. Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010. World J Urol 32, 1587–1594 (2014). https://doi.org/10.1007/s00345-013-1218-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1218-9

Keywords

Navigation